Levi & Korsinsky, LLP: Fraud-On-The-Market Doctrine Underpins Inovio Pharmaceuticals Securities Class Action

NEW YORK, March 23, 2026 (GLOBE NEWSWIRE) -- Shareholder rights firm Levi & Korsinsky, LLP is representing investors in Inovio Pharmaceuticals, Inc. (NASDAQ: INO) who purchased securities during the Class Period. THE INVESTIGATION: The action alleges that Inovio and certain officers made false or misleading statements during the period from October 10, 2023 through December 26, 2025. The Efficient Market Hypothesis Securities class actions often rely on the efficient market hypothesis — the theory that in a ...